全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

Barrier of Hypertensive Drugs among Patients in Tanzania: Case Study of Southern Highlands, Tanzania

DOI: 10.4236/oalib.1108987, PP. 1-7

Subject Areas: Cardiology

Keywords: Barrier, Hypertensive Drugs, Mortality, Cultural Factors, Tanzania

Full-Text   Cite this paper   Add to My Lib

Abstract

Experience with patients shows that prescribed drugs for treating hypertension disease fail to work effectively, causing high mortality rates in African Ethnic types. This situation has resulted in the query as to why the situation exists. The study was conducted to investigate factors affecting the failure of hyper-tension drugs among patients suffering from the disease. Particularly, the study aimed at examining cultural, individual and financial factors affecting drug failure among Tanzania patients. The sample consisted of 300 respondents from Afya Medicare Specialized Clinic and Mbeya Referral hospital in Tan-zania. Questionnaires were distributed and interviews were conducted with pa-tients and their caretakers, doctors and nurses in both health centres. The study revealed that the drugs fail to provide relief to the patients because of the neg-ative attitude towards the consumption of the drugs in the belief that the dis-eases affected only rich people and developed countries. From the findings, it was concluded that education should be provided to the patients as well as their caretakers on the fact that the disease can affect anyone and emphasize preventive measures.

Cite this paper

Nyagori, H. E. and Sakinoi, B. L. (2022). Barrier of Hypertensive Drugs among Patients in Tanzania: Case Study of Southern Highlands, Tanzania. Open Access Library Journal, 9, e8987. doi: http://dx.doi.org/10.4236/oalib.1108987.

References

[1]  Elliott, W.J. (2003) The Economic Impact of Hypertension. Journal of Clinical Hyper-tension, 5, 1-13. https://doi.org/10.1111/j.1524-6175.2003.02463.x
[2]  Australian Federal Government. Australian Institute of Health and Welfare. High Blood Pressure. http://www.aihw.gov.au/high-blood-pressure/
[3]  Whelton, P.K. et al. (2002) Primary Prevention of Hypertension: Clinical and Public Health Advisory from the National High Blood Pressure Education Program. Journal of the American Medical Association, 288, 1882-1888. https://doi.org/10.1001/jama.288.15.1882
[4]  Stevens, V., et al. (1993) Weight Loss Intervention in Phase 1 of the Trials of Hyper-tension Prevention. Archives of Internal Medicine, 153, 849-858. http://archinte.ama-assn.org/cgi/content/abstract/153/7/849
https://doi.org/10.1001/archinte.1993.00410070039006
[5]  Chockalingam, A. (2007) Impact of World Hypertension Day. The Canadian Journal of Cardiology, 23, 517-519. https://doi.org/10.1016/S0828-282X(07)70795-X
[6]  American Heart Foundation (2000) Resistance Exercise in Individuals with and without Cardiovascular Disease: Benefits, Rationale, Safety, and Prescription—An Advisory from the Committee on Exercise, Rehabilitation, and Prevention, Council on Clinical Cardiology. Circulation, 101, 828-833. http://circ.ahajournals.org/content/101/7/828/T1.expansion.html
https://doi.org/10.1161/01.CIR.101.7.828
[7]  Sorace, P., et al. (2009) Hypertension and Resistance Training. Strength and Condi-tioning Journal, 31, 33-35. https://doi.org/10.1519/SSC.0b013e318195bb29 http://www.cross-fitllc.com/wp-content/uploads/2010/06/Hypertension-and-Resistance-Training.pdf
[8]  Cornelissen, V.A. and Fagard, R.H. (2005) Effects of Endurance Training on Blood Pressure, Blood Pressure—Regulating Mechanisms, and Cardiovascular Risk Factors. Hypertension, 46, 667-675. http://hyper.ahajournals.org/content/46/4/667.full https://doi.org/10.1161/01.HYP.0000184225.05629.51
[9]  American College of Sports Medicine (2009) ACSM’s Guidelines for Exercise Testing and Prescription. Lippincott Williams & Wilkins, Philadelphia.
[10]  Hypertension/High Blood Pressure Health Center. Exercise Tips for Those with High Blood Pressure. http://www.webmd.com/hypertension-high-blood-pressure/guide/safe-exercise-tips
[11]  Fagard, R.H. (1999) Physical Activity in the Prevention and Treatment of Hypertension in the Obese. Medicine & Science in Sports & Exercise, 31, s624. https://doi.org/10.1097/00005768-199911001-00022
[12]  Lewis, S.P. (2013) The NICE Hypertension Guideline Update 2006: A Welcome Revi-sion. British Journal of Hospital Medicine, 67, 454-455. https://doi.org/10.12968/hmed.2006.67.Sup9.21995
[13]  Arguedas, J.A., Leiva, V. and Wright, J.M. (2020) Blood Pressure Targets in Adults with Hypertension. The Cochrane Database of Systematic Reviews, 12, Article ID: CD004349. https://doi.org/10.1002/14651858.CD004349.pub3
[14]  Qaseem, A., Wilt, T.J., Rich, R., Humphrey, L.L., Frost, J. and Forciea, M.A. (2017) Pharmacologic Treatment of Hypertension in Adults Aged 60 Years or Older to Higher Versus Lower Blood Pressure Targets: A Clinical Practice Guideline from the Ameri-can College of Physicians and the American Academy of Family Physicians. Annals of Internal Medicine, 166, 430-437. https://doi.org/10.7326/M16-1785

Full-Text


comments powered by Disqus

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133

WeChat 1538708413